Abstract
Malnutrition in infants under six months of age (u6m) is poorly identified and managed in many countries, increasing these children’s risk of poor growth and development and preventable mortality and morbidity. New 2023 WHO malnutrition guidelines recommend assessment, classification and treatment at primary health care level. This study aimed to assess primary health facility availability and readiness for WHO-recommended nutritional care in infants u6m.
We adapted the WHO Harmonized Health Facility Assessment (HHFA) with additional items for Management of small and nutritionally At-risk Infants u6m and their Mothers (MAMI): the HHFA-MAMI tool. Methods included survey of health care providers, direct observation and data extraction from routine registers to calculate mean percentages of a set of items for different readiness areas. We assessed 15 primary health facilities in Senegal, focusing on the five contact points for infants u6m: delivery and postnatal care, immunization programmes, sick child clinics and community health care.
The HHFA-MAMI mean scores (n=15) were: general service availability 51%, general service readiness 69%, management & finance 50%, clinical quality of care 47%. MAMI availability scored 48% and readiness 35%, MAMI infrastructure scored 72%, health workforce 61%, assess MAMI 54%, classify MAMI 15% and treat MAMI 38%, equipment 33% and guidelines & training 22%. Service utilization was highest in postnatal care and immunization contact points, MAMI availability & readiness was highest in delivery and postnatal care.
We conclude that primary health facilities in Senegal have potential to care for infants u6m at risk of poor growth and development with high general PHC readiness and frequent use of care contact points for infants u6m. MAMI availability and readiness require improvements to provide WHO-recommended care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The principal investigator received a small grant from Otto Kranendonk Fonds, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the National Ethics Committee in Senegal (Ref: SEN 19/78) and LSHTM (Ref: 28311).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
removed inter quartile range from the results
Data Availability
The complete list of items of our HHFA-MAMI survey tool is available in Supplementary file 1. The survey and anonymised results presented in this study are available from the LSHTM data repository on request with the corresponding author (https://datacompass.lshtm.ac.uk/).
https://datacompass.lshtm.ac.uk/cgi/users/home?screen=EPrint::View&eprintid=3819#t
